Summary
We had the honour to see our latest article titled "What US trial sponsors should know about the GDPR" published in BioPharma Dive. In this article, we discuss what the GDPR is and why it matters to Life Sciences company. We also show how iliomad Health Data can help companies maintain GDPR compliance.
Link to the article :
https://www.biopharmadive.com/spons/what-us-trial-sponsors-should-know-about-the-gdpr/654291/
Sign up for our newsletter
We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
Sign up for our newsletter
We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
Vendor GDPR in Clinical Trials: What the IQVIA CNIL Ruling Changes for Sponsors and Healthtech Companies
On 26 May 2026 the CNIL fined IQVIA Operations France EUR 5 million for failures in its two authorised health data warehouses, LRX and EMR. The decision exposes weaknesses in CRO data protection practice that have direct consequences for every pharmaceutical sponsor relying on a CRO to process patient, prescription or trial data. This article unpacks the four areas of failure, explains why pseudonymisation no longer offers the cover many sponsors assume, and sets out a practical oversight checklist for sponsor data controllers.
EU AI Act for Healthcare: What Life Sciences Companies Need to Know before August 2026
EU AI Act 2026 healthcare enforcement requires immediate compliance to avoid penalties.
Navigating US Regulatory Requirements for AI-Powered Medical Devices: A Comprehensive Guide to FDA, HIPAA, and IRB Compliance
US AI medical device compliance requires navigating FDA, HIPAA, IRBs, and consent waivers strategically.
FAQs
Our frequently questions